Phosphoprotein levels, MAPK activities and NFκkB expression are affected by fisetin

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 22, Issue 4, 2007, Pages 439-444

  de Sousa, Roberta R Ruela ^a   Queiroz, Karla Cristiana Souza ^a   Souza, Ana Carolina Santos ^a   Gurgueira, Sonia A ^b   Augusto, Amanda Cavallari ^b   Miranda, Marcio André ^a   Peppelenbosch, Maikel P ^c   Ferreira, Carmen Veríssima ^a   Aoyama, Hiroshi ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b UNIVERSIDADE SÃO FRANCISCO   (Brazil)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

Author keywords

Fisetin; Flavonoids; HL60; MAPK; NF B; Phosphatases

Indexed keywords

FISETIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE P38; PHOSPHATASE; PHOSPHOPROTEIN; PROTEIN KINASE;

ANTIOXIDANT ACTIVITY; APOPTOSIS; ARTICLE; CELL STRAIN HL 60; CELL TYPE; CONTROLLED STUDY; DRUG STRUCTURE; DRUG UPTAKE; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN CELL; OXIDATION REDUCTION STATE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION;

ANTIOXIDANTS; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SCREENING ASSAYS, ANTITUMOR; FLAVONOIDS; HL-60 CELLS; HUMANS; LYMPHOCYTES; MAP KINASE SIGNALING SYSTEM; MODELS, CHEMICAL; NF-KAPPA B; OXIDATIVE STRESS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION;

EID: 34547760465     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360601162063     Document Type: Article

References (49)

1. Middleton Jr, E. and Kandaswami, C. (1993) The impact of plant flavonoids on mammalian biology: Implications for immunity, inflammation and cancer. The Flavonoids: Advances in Research Since 1986, pp. 619-652. New York
2. Verbeek, R., Plomp, AC, van Tol, EA and van Noort, JM (2004) The flavones luteolin and apigenin inhibit in vitro antigen-specific proliferation and interferon-gamma production by murine and human autoimmune T cells. Biochem Pharmacol, 68, pp. 621-629.
3. Middleton Jr, E., Kandaswami, C. and Theoharides, TC (2000) The effects of plant flavonoids on mammalian cells: Implications for inflammation, heart disease, and cancer. Pharmacol Rev, 52, pp. 673-751.
4. Hendriks, JJ, de Vries, HE, van der Pol, SM, Berg, TK van den, van Tol, EA and Dijkstra, CD (2003) Flavonoids inhibit myelin phagocytosis by macrophages; A structure-activity relationship study. Biochem Pharmacol, 65, pp. 877-885.
5. Ferriola, PC, Cody, V. and Middleton, E. (1989) Protein kinase C inhibition by plants flavonoids. Kinetic mechanisms and structure-activity relationships. Biochem Pharmacol, 38, pp. 1617-1624.
6. Agullo, G., Garnet-Payrustre, L., Manenti, S., Viala, C., Rémésy, C., Chap, H. and Payrustre, B. (1997) Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-Kinase: A comparison with Tyrosine Kinase and Protein Kinase C inhibition. Biochem Pharmacol, 53, pp. 1649-1657.
7. Sagara, Y., Vanhnasy, J. and Maher, P. (2004) Induction of PC12 cell differentiation by flavonoids is dependent upon extracellular signal-regulated kinase activation. J Neurochem, 90, pp. 1144-1155.
8. Kimira, M., Arai, Y., Shimoi, K. and Watanabe, S. (1998) Japanese intake of flavonoids and isoflavanoids from foods. J Epidemiol, 8, pp. 168-175.
9. Osheroff, N., Zechiedrich, EL and Gale, KC (1991) Catalytic function of DNA topoisomerase II. BioEssays, 13, pp. 269-275.
10. Olaharski, AJ, Mondrala, ST and Eastmond, DA (2005) Chromosomal malsegregation and micronucleus induction in vitro by the DNA topoisomerase II inhibitor fisetin. Mut Res, 582, pp. 79-86.
11. van Acker, FAA, Schouten, O., Haenen, GRMM, van der Vijh, WJF and Bast, A. (2000) Flavonoids can replace alpha-tocopherol as an antioxidant. FEBS Lett, 473, pp. 145-148.
12. Pietta, PG (2000) Flavonoids as antioxidants. J Nat Prod, 63, pp. 1035-1042.
13. 2+-dependent endonuclease. Biochem Pharmacol, 63, pp. 225-236.
14. Fotsis, T., Pepper, MS, Aktas, E., Breit, S., Rasku, S., Adlercreutz, H., Wahala, K., Montesano, R. and Schweigerer, L. (1997) Flavonoids, dietary-derived inhibitors of cell proliferation and in vivo angiogenesis. Cancer Res, 57, pp. 2916-2921.
15. Haddad, AQ, Venkateswaran, V., Viswanathan, L., Teahan, SJ, Fleshner, NE and Klotz, LH (2006) Novel antiproliferative flavonoids induce cell cycle arrest in human prostate cancer cell lines. Prostate Cancer Prostatic Dis, 9, pp. 68-76.
16. Park, JB (1999) Flavonoids are potential inhibitors of glucose uptake in U937 cells. Biochem Biophys Res Commun, 260, pp. 568-574.
17. Bromberg, N., Justo, GZ, Haun, M., Duran, N. and Ferreira, CV (2005) Violacein toxicity on human blood lymphocytes and effect on phosphatases. J Enz Inhib Med Chem, 20, pp. 449-454.
18. Hartree, EF (1972) Determination of proteins: A modification of the Lowry method that give a linear photometric response. Anal Biochem, 48, pp. 422-427.
19. McCord, JM and Fridovich, I. (1969) Superoxide dismutase. An enzymic function for erythrocuprein (hemocuprein). J Biol Chem, 244, pp. 6049-6055.
20. Beauchamp, CO and Fridovich, I. (1973) Isozymes of superoxide dismutase from wheat germ. Biochim Biophys Acta, 317, pp. 50-64.
21. Nelson, DP and Kiesow, LA (1972) Enthalpy of decomposition of hydrogen peroxide by catalase at 25°C. Anal Biochem, 49, pp. 474-478.
22. Lawrence, RA and Burk, RF (1976) Glutathione peroxidase activity in selenium-deficient rat liver. Biochem Biophys Res Commun, 71, pp. 952-958.
23. Morton, RL, Iklé, D. and White, CW (1998) Loss of lung mitochondrial aconitase activity due to hyperoxia in bronchopulmonary dysplasia in primates. Am J Physiol Lung Cell Mol Physiol, 274, pp. L127-L133.
24. Racker, E. (1950) Spectrophotometric measurements of the enzymatic formation of fumaric acid and cis-aconitic acid. Biochim Biophys Acta, 4, pp. 211-214.
25. Freire, AG, Melo, PS, Haun, M., Duran, N., Aoyama, H. and Ferreira, CV (2003) Cytotoxic effect of the diterpene lactone dehydrocrotonin from Croton cajucara on human promyelocytic leukemia cells. Planta Med, 69, pp. 67-69.
26. Justo, GZ and Ferreira, CV (2005) Coagulation and cancer therapy: The potential of natural compounds. Cur Genomics, 6, pp. 461-469.
27. De Fátima, A., Modolo, LV, Conegero, LS, Pilli, RA, Ferreira, CV, Kohn, K. and de Carvalho, JE Styryl lactones and their derivatives: Biological activities, mechanisms of action and potential leads for drug design. Cur Med Chem
28. O'Gorman, DM and Cotter, TG (2001) Molecular signals in anti-apoptotic survival pathways. Leukemia, 15, pp. 21-34.
29. Makin, G. and Dive, C. (2001) Apoptosis and cancer chemotherapy. Trends Cell Biol Sci, 11, pp. S22-S26.
30. Martelli, AM, Tazzari, PL, Tabellini, G., Bortul, R., Billi, AM, Manzoli, L., Ruggeri, A., Conte, R. and Cocco, L. (2003) A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells. Leukemia, 17, pp. 1794-1805.
31. Chen, YC, Shen, SC, Lee, WR, Lin, HY, Ko, CH, Shih, CM and Yang, LL (2002) Wogonin and fisetin induction of apoptosis through activation of caspase 3 cascade and alternative expression of p21 protein in hepatocellular carcinoma cells SK-HEP-1. Arch Toxicol, 76, pp. 351-359.
32. Williams, RJ, Spencer, JPE and Rice-Evans, C. (2004) Flavonoids: Antioxidants or signaling molecules?. Free Radic Biol Med, 36, pp. 838-849.
33. Kanno, S., Tomizawa, A., Ohtake, T., Koiwai, K., Ujibe, M. and Ishikawa, M. (2006) Naringenin-induced apoptosis via activation of NF-κB and necrosis involving the loss of ATP in human promyeloleukemia HL-60 cells. Toxicol Lett, 166, pp. 131-139.
34. Pahl, HL (1999) Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene, 18, pp. 6853-6866.
35. Ricca, A., Biroccio, A., Trisciuoglio, D., Cippitelli, M., Zupi, G. and Bufalo, D del (2001) relA overexpression reduces tumorigenicity and activates apoptosis in human cancer cells. Brit J Cancer, 85, pp. 1914-1921.
36. Kroemer, G., Zamzami, N. and Susin, SA (1997) Mitochondrial control of apoptosis. Immunol Today, 18, pp. 45-51.
37. Dumont, A., Hehner, SP, Hofmann, TG, Ueffing, M., Dröge, W. and Schmitz, ML (1999) Hydrogen peroxide-induced apoptosis is CD95-independent, requires the release of mitochondria-derived reactive oxygen species and the activation of NF-kB. Oncogene, 18, pp. 747-757.
38. Lin, KI, Lee, SH, Narayanan, R., Baraban, JM, Hardwick, JM and Ratan, RR (1995) Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kB. J Cell Biol, 131, pp. 1149-1161.
39. Carter, BD, Kaltschmidt, C., Kaltschmidt, B., Offenhauser, N., Bohm, MR, Baeuerle, PA and Barde, YA (1996) Selective activation of NF-kappaB by nerve growth factor through the neurotrophin receptor p75. Science, 272, pp. 542-545.
40. Grimm, S., Bauer, MK, Baeuerle, PA and Osthoff, K Schulze (1996) Bcl-2 downregulates the activity of transcription factor NF-kappaB induced upon apoptosis. J Cell Biol, 134, pp. 13-23.
41. Lin, B., Williams-Skipp, C., Tao, Y., Schleicher, MS, Cano, LL, Duke, RC and Scheinman, RI (1999) NF-kB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death Diff, 6, pp. 570-582.
42. Grilli, M. and Memo, M. (1999) Nuclear factor kappa B/Rel proteins: A point of convergence of signaling pathways relevant in neuronal function and dysfunction. Biochem Pharmacol, 57, pp. 1-7.
43. Liang, LP and Patel, M. (2004) Iron-sulfur enzyme mediated mitochondrial superoxide toxicity in experimental Parkinson's disease. J Neurochem, 90, pp. 1076-1084.
44. Sakon, S., Xue, X., Takekawa, M., Sasazuki, T., Okazaki, T., Kojima, Y., Piao, JH, Yagita, H., Okumura, K., Doi, T. and Nakano, H. (2003) NFkB inhibits TNFα-induced accumulation of ROS that mediate prolonged MAPK activation and necrotic cell death. EMBO J, 22, pp. 3898-3909.
45. Pham, CG, Bubici, C., Zazzeroni, F., Papa, S., Alvarez, K., Jayawardena, S., De Smaele, E., Cong, R., Beaumont, C., Torti, FM, Torti, SV and Franzoso, G. (2004) Feritin heavy chain upregulation by NF-κ inhibits TNFα-induced apoptosis by suppressing reactive oxygen species. Cell, 119, pp. 529-542.
46. Ventura, JJ, Cogswell, P., Flavell, RA, Baldwin Jr, AS and Davis, RJ (2004) JNK potentiates TNF-stimulated necrosis by increasing the production of cytotoxic reactive oxygen species. Genes Dev, 18, pp. 2905-2915.
47. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H. and Karin, M. (2005) Reactive oxygen species promote TNFα-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell, 120, pp. 649-661.
48. Davis, RJ (2000) Signal transduction by the JNK group of MAP kinases. Cell, 103, pp. 239-252.
49. Sumbayev, VV and Yasinska, IM (2005) Regulation of MAP kinase-dependent apoptotic pathway: Implication of reactive oxygen and nitrogen species. Arch Biochem Biophys, 436, pp. 406-412.